Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Orthofix Medical Inc. (OFIX) Guidance & Earnings Results

On 2026-08-05 Orthofix Medical Inc. raised guidance: "Net sales +$7M at both ends; adj EBITDA +$5M at both…" — from its own filing, as read by EquiReason.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

OFIXOrthofix Medical Inc.Follow OFIX — free
Medical Devices · Healthcare
—
Price chart with a free account
Market cap
399.6M
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
11 Nov, in 18 days

What management guided

each earnings 8-K · figures checked against the filing text
ReleaseDirectionWhat they said
5 Aug 26RaisedNet sales +$7M at both ends; adj EBITDA +$5M at both ends · full year
9 Apr 26ReaffirmedNet sales $850-860M; adj. EBITDA $95-98M; positive FCF · full year
24 Feb 26Raised2026 financial guidance provided; three-year targets updated · full year
4 Nov 25RaisedNet sales guidance narrowed to $810-814M (midpoint maintained); low-end of adjusted EBITDA raised · full year
5 Aug 25ReaffirmedFY2025 pro forma net sales $808-816M; FY2025 pro forma non-GAAP adjusted EBITDA $82-86M; FY2025 free cash flow positive · full year

Orthofix Medical Inc. — questions

What guidance did Orthofix Medical Inc. give?
On 2026-08-05: "Net sales +$7M at both ends; adj EBITDA +$5M at both ends"
When does Orthofix Medical Inc. report earnings?
Orthofix Medical Inc.'s next earnings report is expected on 2026-11-11.

Every figure on this page comes from Orthofix Medical Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.